Zhang Zongsu, Ma Xiaocheng, Li Zhaochen, Wei Haotian, Jia Kaipeng, Xu Chenglong, Zhu Shimiao, Wen Simeng, Quan Changyi
Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Int J Med Sci. 2025 Jul 28;22(14):3581-3590. doi: 10.7150/ijms.112777. eCollection 2025.
Hypertension is a major public health problem. In clinical practice, we have observed that when hypertensive patients undergo robotic-assisted partial nephrectomy (RAPN), approximately half of them experience a normalization of their blood pressure (BP) shortly after the surgery. This study aims to investigate the effect of RAPN on BP in hypertensive patients with renal tumor by disassociating nerve tissue around the renal artery. We reviewed patients with renal tumor requiring RAPN who were admitted to our department from January 2021 to January 2024, with a minimum follow-up of 3 months. A total of 260 hypertensive patients combined with renal tumor were followed up. Univariate and multivariate logistic regression analyses were sequentially employed to determine the factors associated with blood pressure normalization following RAPN. Finally, a nomogram model based on independent risk factors was established and validated. A total of 55.38% (144/260) hypertensive patients combined with renal tumor have achieved blood pressure normalization following RAPN. A multivariate logistic regression analysis showed that preoperative BP (OR=0.145; 95%CI:0.052-0.421; p<0.001), circulatory diseases(OR=15.661; 95%CI:8.611-30.576; p<0.001), plasma renin activity ratio(PRA) (OR=0.071; 95%CI:0.035-0.131; p<0.001), preoperative angiotensin II (AT II) (OR=0.693; 95%CI:0.551-0.861; p=0.002), Body Mass Index (BMI) (OR=0.526; 95%CI:0.355-0.713; p=0.031) were independently correlated with blood pressure normalization. We constructed a nomogram prediction model based on these independent risk factors. Validation through receiver operating characteristic curve, calibration curves, and decision curve analysis demonstrated a strong correlation between predicted and actual occurrence probabilities. This procedure blocks the renin-angiotensin-aldosterone system by disassociating nerve tissue around the renal artery in hypertensive patients, thereby reducing their BP. This surgical method may become a potential new treatment for hypertension in the future.
高血压是一个主要的公共卫生问题。在临床实践中,我们观察到高血压患者接受机器人辅助部分肾切除术(RAPN)后,约有一半患者在术后不久血压恢复正常。本研究旨在通过分离肾动脉周围的神经组织,探讨RAPN对肾肿瘤高血压患者血压的影响。我们回顾了2021年1月至2024年1月入住我科、需要进行RAPN且至少随访3个月的肾肿瘤患者。共对260例合并肾肿瘤的高血压患者进行了随访。依次采用单因素和多因素logistic回归分析来确定与RAPN后血压恢复正常相关的因素。最后,建立并验证了基于独立危险因素的列线图模型。共有55.38%(144/260)的合并肾肿瘤的高血压患者在RAPN后实现了血压正常化。多因素logistic回归分析显示,术前血压(OR=0.145;95%CI:0.052-0.421;p<0.001)、循环系统疾病(OR=15.661;95%CI:8.611-30.576;p<0.001)、血浆肾素活性比值(PRA)(OR=0.071;95%CI:0.035-0.131;p<0.001)、术前血管紧张素II(AT II)(OR=0.693;95%CI:0.551-0.861;p=0.002)、体重指数(BMI)(OR=0.526;95%CI:0.355-0.713;p=0.031)与血压正常化独立相关。我们基于这些独立危险因素构建了列线图预测模型。通过受试者工作特征曲线、校准曲线和决策曲线分析进行验证,结果表明预测概率与实际发生概率之间存在很强的相关性。该手术通过分离高血压患者肾动脉周围的神经组织来阻断肾素-血管紧张素-醛固酮系统,从而降低其血压。这种手术方法未来可能成为治疗高血压的一种潜在新疗法。